266.97
Precedente Chiudi:
$265.53
Aprire:
$264.7
Volume 24 ore:
503.75K
Relative Volume:
1.02
Capitalizzazione di mercato:
$10.34B
Reddito:
$1.24B
Utile/perdita netta:
$42.23M
Rapporto P/E:
251.86
EPS:
1.06
Flusso di cassa netto:
$150.33M
1 W Prestazione:
-0.58%
1M Prestazione:
-10.08%
6M Prestazione:
+9.36%
1 anno Prestazione:
+42.00%
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Confronta PEN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PEN
Penumbra Inc
|
266.97 | 10.40B | 1.24B | 42.23M | 150.33M | 1.06 |
![]()
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-14 | Iniziato | BofA Securities | Buy |
2025-01-21 | Iniziato | UBS | Buy |
2024-12-17 | Iniziato | Oppenheimer | Outperform |
2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2024-09-18 | Iniziato | Stifel | Buy |
2024-09-03 | Iniziato | Leerink Partners | Outperform |
2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
2023-07-19 | Iniziato | Robert W. Baird | Outperform |
2023-03-29 | Downgrade | Needham | Buy → Hold |
2023-01-30 | Iniziato | Piper Sandler | Overweight |
2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
2022-10-12 | Iniziato | Jefferies | Buy |
2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
2022-09-09 | Aggiornamento | Needham | Hold → Buy |
2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
2022-04-19 | Iniziato | Deutsche Bank | Buy |
2022-03-08 | Iniziato | Needham | Hold |
2021-09-16 | Iniziato | Truist | Buy |
2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
2020-10-07 | Ripresa | Canaccord Genuity | Buy |
2020-09-29 | Iniziato | BTIG Research | Buy |
2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
2020-03-05 | Iniziato | Citigroup | Buy |
2019-06-13 | Reiterato | BofA/Merrill | Buy |
2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
2019-05-21 | Iniziato | William Blair | Outperform |
2018-10-29 | Ripresa | BofA/Merrill | Buy |
2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
2018-02-21 | Iniziato | William Blair | Outperform |
2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
2015-11-30 | Reiterato | Canaccord Genuity | Buy |
2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
Penumbra CEO Adam Elsesser sells $4.37 million in stock By Investing.com - Investing.com Canada
Penumbra CEO Adam Elsesser sells $4.37 million in stock - Investing.com Australia
Penumbra Amends Incorporation Certificate After Stockholder Vote - TipRanks
Managing Acute Limb Ischemia With Penumbra Lightning Bolt™ Technology - HMP Global Learning Network
Why Investors Shouldn't Be Surprised By Penumbra, Inc.'s (NYSE:PEN) P/S - simplywall.st
Why Is Penumbra (PEN) Down 10.6% Since Last Earnings Report? - Yahoo Finance
Penumbra (NYSE:PEN) shareholders are still up 88% over 3 years despite pulling back 3.1% in the past week - Yahoo Finance
Penumbra, Inc. to Present at Upcoming Investor Conferences - Eastern Progress
Penumbra Rallies 35.9% in a Year: What's Driving the Stock? - sharewise
Penumbra, Inc. to Present at Upcoming Investor Conferences | PEN Stock News - GuruFocus
Blend Extra: Stroke Awareness Month And How Quick Action Can Save Lives - TMJ4 News
Insider Sell Alert: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Here's Why Penumbra (PEN) is a Strong Momentum Stock - Yahoo Finance
Penumbra EVP Johanna Roberts sells $268,697 in stock By Investing.com - Investing.com Nigeria
Penumbra EVP Johanna Roberts sells $268,697 in stock - Investing.com
Here's Why Penumbra (PEN) is a Strong Growth Stock - Yahoo Finance
Stroke Awareness Month: Quick Action Can Save Lives - ABC Action News
Transcript : Penumbra, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com
PEN INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now - ACCESS Newswire
PEN Q1 Earnings Call: U.S. Thrombectomy Drives Outperformance as International Headwinds Persist - Yahoo Finance
Penumbra stock surges on approval hopes By Investing.com - Investing.com Canada
Should You Consider Adding Penumbra (PEN) To Your Portfolio? - Insider Monkey
Penumbra CFO Maggie Yuen sells $598,020 in common stock - Investing.com
3 Mid-Cap Medical Stocks Outperforming the Market - The Globe and Mail
Penumbra’s SWOT analysis: stock poised for growth amid innovation and challenges - Investing.com Australia
LAWSUIT FILED: Penumbra, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP - ACCESS Newswire
SHAREHOLDER ALERT: Penumbra, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm - ACCESS Newswire
Penumbra Inc.: Can Its Innovation & Product Pipeline Foster Long-Term Growth & Competitiveness? - Smartkarma
Penumbra, Inc. Reports First Quarter 2025 Financial Results - Eastern Progress
We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings - simplywall.st
Penumbra, Inc. to Present at the BofA Securities 2025 Health Car - GuruFocus
Exclusive: Penumbra Management Team Set for Key Presentation at BofA Healthcare Conference - Stock Titan
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference - Longview News-Journal
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
3 Reasons Growth Investors Will Love Penumbra (PEN) - Yahoo Finance
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Ischemic Neurological Interventional Medical Devices Market - openPR.com
Penumbra projects 12%-14% revenue growth for 2025 amid strong thrombectomy performance - MSN
Penumbra, Inc. (NYSE:PEN) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings Beat: Penumbra, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Penumbra EVP Roberts sells shares worth $180,006 By Investing.com - Investing.com Canada
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):